DirectoryMix Web Resources » Article Details

Foundation Supports Technology Aimed at Destroying Cancer Cells - Read More

Date Added: August 13, 2008 08:20:13 PM
The technology, irreversible electroporation, which uses electric pulses to destroy cancer tissue, has been selected for an Early Career Translational Research Award in Biomedical Engineering in order to support commercial development.

Category: Science and Technology » Biology


No comments are posted yet


 
Name:*
Email:*
Website:  (optional)
Comment:*
(html and bb codes are filtered and not allowed)

Do the math:*CAPTCHA - Do The Math
 

Related Articles

Biology and beyond

For more than three decades, Sandy Wardell has taught her students with the philosophy that biology education should go beyond lectures and tests by incorporating inquiry and hands-on labs, case studies and technology-based activities.

Achieving Top Grades In Science Subjects More Difficult, Research Shows

Schoolchildren in the UK studying science and technology subjects like maths, physics and chemistry find it much harder to achieve the top exam grades than candidates of similar ability studying subjects like media studies and psychology, according to a n

Students thrive in marine biology program

A student from Lake Forest High School and one from Deerfield High School recently returned from the Bahamas, where they spent a week experiencing first-hand marine biology as part of a Shedd Aquarium's program. Logan Schwarzman and John Clark, soon-to-b

Science teacher delivers lesson from under the sea

Sixty-three feet below the ocean's surface, the science teacher was giving his morning lesson. "Hi, and welcome to Aquarius for our third and final broadcast from this mission," Mark Tohulka told his third-period marine biology students, watching via w

Novel Therapeutic Strategy For Colon Cancer Treatment

A team of scientists at the Genome Institute of Singapore (GIS), a research institute of the Asian city-state's Agency for Science, Technology and Research (A*STAR), and the University of California at San Francisco have developed a pharmacological appro